Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its financial results for Q1 2023 on May 3, 2023, at 4:00 p.m. ET, followed by a conference call on May 4, 2023, at 8:30 a.m. ET. Interested parties can access the call via an audio webcast on Axcelis' Investors page. The company, headquartered in Beverly, Massachusetts, specializes in high-productivity solutions for the semiconductor industry, focusing on ion implantation systems and complete life cycle support. For more information, visit www.axcelis.com.
Axcelis Technologies (Nasdaq: ACLS) announced the significant milestone of shipping its 500th Purion™ ion implanter system to a major semiconductor manufacturer in North America. This achievement underscores Axcelis' market leadership in providing ion implantation solutions for the semiconductor industry. According to President and CEO Mary Puma, this shipment validates the company’s strong customer partnerships and expanding manufacturing capabilities. The growing installed base of Purion systems is expected to bolster Axcelis' aftermarket business. The Purion platform is recognized for its advanced technology, particularly in image sensor and power device manufacturing.
Axcelis Technologies (Nasdaq: ACLS) has appointed Russell J. Low, Ph.D., as President and CEO effective May 11, 2023. He will succeed Mary G. Puma, who will become Executive Chairperson and remain a Senior Advisor. Dr. Low, previously Executive VP of Global Customer Operations and Engineering, played a key role in developing the Purion ion implant product line. Puma, who has led Axcelis for 22 years, emphasized the timing for this transition as ideal for future growth. The board expressed confidence in Dr. Low's leadership, highlighting his technical expertise and commitment to innovation, promising continued market leadership and value delivery.
Axcelis Technologies (NASDAQ: ACLS) announced on March 12, 2023, that the recent collapse of Silicon Valley Bank (SVB) is expected to have an immaterial impact on its operations. The company has an unused line of credit with SVB and maintains banking relationships with multiple US and foreign banks. As of December 31, 2022, Axcelis had $185.6 million in cash and cash equivalents, with $246.6 million in short-term investments primarily in U.S. Government securities. The company's liquidity will remain unaffected, and it has instructed clients to remit payments to non-SVB accounts.
Axcelis Technologies, Inc. (NASDAQ: ACLS), a semiconductor equipment supplier, announced on March 12, 2023, that the recent collapse of Silicon Valley Bank (SVB) will have an immaterial impact on its operations. The company highlighted its robust banking relationships with multiple U.S. and foreign banks, ensuring no liquidity issues. As of December 31, 2022, Axcelis held $185.6 million in cash and cash equivalents, alongside $246.6 million in short-term investments in U.S. Government and Agency securities. The company is taking steps to move deposits and ensure customer payments are unaffected.
Axcelis Technologies (Nasdaq: ACLS), based in Beverly, Mass., has announced its participation in two upcoming investor conferences. The first is the Susquehanna Financial Group Twelfth Annual Technology Conference, scheduled for March 2-3, 2023, at the Lotte New York Palace Hotel. Management will hold one-on-one meetings with investors on March 2. The second event is the Loop Capital Markets 2023 Investor Conference, taking place virtually on March 13 and in-person on March 14, 2023, also at the Lotte New York Palace Hotel, with one-on-one meetings on the latter date. Axcelis has over 40 years of experience providing ion implantation solutions for the semiconductor industry.